InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Fundaro Paolo, 董事. Director active across 1 company, notably Intercept Pharmaceuticals, INC.. Cumulatively, 4 disclosures have been recorded. History available since 27 May 2021. The latest transaction was disclosed on 8 November 2023 (U). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Fundaro Paolo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
35,794 股@ US$19.00100.0% 占其流量Common StockSEC:0001104659-23-117113:0
8,111 股0Common StockSEC:0001104659-23-064843:0
7,737 股0Common StockSEC:0001104659-22-065927:0
7,029 股0Common StockSEC:0001104659-21-075218:0
4 条申报中的 4 条
About Fundaro Paolo
Paolo Fundaro is a Board Member at INTERCEPT PHARMACEUTICALS, INC. He contributes to the governance of the company by bringing his expertise and participating in strategic decisions within the board of directors.
